Capital One has taken over Webster Equity Partners’ portfolio company, Discovery Behavioral Health. Court documents show that Capital One and its

LOS ANGELES, March 11, 2025 /PRNewswire/ -- Discovery Behavioral Health, Inc. (DBH) announced a newly published study, Changes in Recovery Assessment Scale Scores During a Treatment Episode Among Patients in a Large Behavioral Health Care System, which provides insights into the progress of more than 20,000 Discovery patients who received treatment between 2021 - 2022. The study, published in Psychiatric Services, a journal of the American Psychiatric Association highlights key findings on how Recovery Assessment Scale (RAS) scores evolve over the course of treatment, offering a deeper understanding of patient recovery trajectories.Conducted by a team of researchers from DBH and Brigham and Women's Hospital, the study analyzed data from a large behavioral health care system to assess changes in RAS scores. The Recovery Assessment Scale is a widely used tool for measuring patient perceptions of their own recovery, making this research particularly relevant for clinicians, policymakers, and behavioral health professionals seeking to improve treatment outcomes.The study revealed that substantial improvements in recovery were evident during treatment, especially for patients with lower RAS scores at admission. Among 20,770 patients (contributing 27,002 treatment episodes) receiving treatment at DBH in the 2021–2022 period, 15,059 patients (representing 18,147 episodes) had RAS and PHQ-9 scores recorded at admission, 9,441 of whom (representing 10,496 treatment episodes) had an RAS score recorded also at discharge were included the cohort. The findings underscore the importance of research into enhanced personalized treatment approaches to optimize recovery.Matt Ruble, MD, Discovery's Chief Medical Officer says, "Precision psychiatry and precise treatments demand a measurement tool that assesses functionality and that tracks recovery

As depression is reduced, patients are statistically more likely to drop out of a behavioral health treatment program as compared with patients with greater depression severity. The study can have implications on how behavioral healthcare treatment is delivered.LOS ANGELES, Aug. 14, 2024 /PRNewswire/ -- A newly released study from Science Direct's Psychiatry Research Communications journal conducted as part of a research support agreement between Brigham and Women's Hospital and Discovery Behavioral Health examines treatment dropout in behavioral health treatment. Understanding the relationship between depression severity, patient recovery, and treatment continuity may help impact and optimize the delivery of future behavioral health services.The study measured the association between treatment dropout and depression severity, as measured by the Patient Health Questionnaire (PHQ-9), and the association between treatment dropout and baseline recovery, as measured by the Recovery Assessment Scale (RAS). The sample of 14,689 patients were treated at Discovery treatment centers in multiple states and included patients from eating disorder, mental health and substance use programs discharged between 2021 and 2022.We are creating new & better ways for our industry to support lifelong recovery. - John Peloquin, CEO, Discovery Post this"These findings lay the foundation for our future work on predictive models and a comprehensive clinical decision support system that will allow us to provide personalized and dynamic treatment regimens to our patients" said Dr